Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

NK cells play a role in skin diseases like eczema and psoriasis.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Early scar classification in lupus can improve treatment and patient outcomes.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Hair casts on the scalp may be a sign of ongoing pemphigus vulgaris and could suggest a need to adjust treatment.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.